Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
STOK Quote, Financials, Valuation and Earnings
Last price:
$31.88
Seasonality move
:
-13.44%
Day range:
$31.68 - $32.80
52-week range:
$5.35 - $38.69
Dividend yield:
0%
P/E ratio:
48.75x
P/S ratio:
9.13x
P/B ratio:
5.96x
Volume:
292.8K
Avg. volume:
1M
1-year change:
184.19%
Market cap:
$1.8B
Revenue:
$36.6M
EPS (TTM):
$0.66
Earnings Data
Next earnings date for STOK
Mar 24
2026
Most recent earnings per share
-$0.65
Missed by $0.08
(Nov 4/2025)
Consensus Estimate
-$0.57
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
STOK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q4 | $5.1M | -- | -- | -$0.72 | -- |
| 11/04/2025 | Q3 | $6.2M | $10.6M | -$0.65 | -$0.57 | -$0.08 |
| 08/12/2025 | Q2 | $5.2M | $13.8M | -$0.40 | -$0.54 | $0.13 |
| 05/06/2025 | Q1 | $31.5M | $158.6M | $1.90 | -$0.09 | $1.99 |
| 03/18/2025 | Q4 | $4.3M | $22.6M | -$0.18 | -$0.53 | $0.35 |
| 11/05/2024 | Q3 | $3.6M | $4.9M | -$0.47 | -$0.54 | $0.07 |
| 08/07/2024 | Q2 | $3.3M | $4.8M | -$0.46 | -$0.56 | $0.10 |
| 05/06/2024 | Q1 | $3.2M | $4.2M | -$0.57 | -$0.61 | $0.04 |
| 03/25/2024 | Q4 | $3.2M | $2.8M | -$0.60 | -$0.63 | $0.03 |
| 11/07/2023 | Q3 | -- | $3.3M | -$0.55 | -- | -- |
| 08/07/2023 | Q2 | -- | -$2.5M | -$0.69 | -- | -- |
| 05/04/2023 | Q1 | -- | $5.2M | -$0.53 | -- | -- |
| 03/10/2023 | Q4 | -- | $3.3M | -$0.65 | -- | -- |
| 11/14/2022 | Q3 | -- | $2.9M | -$0.66 | -- | -- |
| 08/08/2022 | Q2 | -- | $3.2M | -$0.63 | -- | -- |
| 05/10/2022 | Q1 | -- | $3M | -$0.66 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$0.66 | -- | -- |
| 11/08/2021 | Q3 | -- | -- | -$0.61 | -- | -- |
| 08/10/2021 | Q2 | -- | -- | -$0.60 | -- | -- |
| 05/10/2021 | Q1 | -- | -- | -$0.46 | -- | -- |
| 03/09/2021 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$0.41 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | -$0.39 | -- | -- |
| 05/15/2020 | Q1 | -- | -- | -$0.34 | -- | -- |
| 03/23/2020 | Q4 | -- | -- | -$0.31 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$0.26 | -- | -- |
| 08/14/2019 | Q2 | -- | -- | -$1.54 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.18 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.06 | -- | -- |
Stoke Therapeutics, Inc. Earnings Questions
-
How Much did Stoke Therapeutics, Inc. Generate in Revenue Last Quarter?
Stoke Therapeutics, Inc. reported $10.6M worth of top line sales in its most recent quarter.
-
Did Stoke Therapeutics, Inc. Beat Earnings Last Quarter?
Stoke Therapeutics, Inc. announced earnings per share of -$0.65 which represents a miss of analyst forecast a -$0.57 per share.
-
Is Stoke Therapeutics, Inc. Profitable?
Stoke Therapeutics, Inc. reported $9.6M that represents $0.16 per share over the last quarter.
-
What is the Analyst Consensus for Stoke Therapeutics, Inc. EPS Next Year?
Stoke Therapeutics, Inc.'s earnings are forecast to decrease from -$1.65 per share to -$2.02 per share next year representing a decrease of -97.01%.
-
When is Stoke Therapeutics, Inc.'s Earnings Date?
Stoke Therapeutics, Inc.'s next earnings date is March 24, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 3.73% over the past day.
Buy
60
AAOI alert for Dec 26
Applied Optoelectronics, Inc. [AAOI] is down 9.39% over the past day.
